Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX) dog skin supplement hospital emergency antidote medication

hospital emergency antidote medication

Prevents Essential Fatty Acid Deficiency: Supports cell membrane integrity

3V DC balances efficiency and performance

industrial environments

Engineered for optimal performance

Ogivri Trastuzumab-Dkst Injection 150 mg **Refrigeration Required** (RX) dog skin supplement hospital emergency antidote medicationOgivri Trastuzumab Dkst Injection 150 mg is a medication used in the treatment of certain types of breast cancer and stomach cancer. It contains the active ingredient trastuzumab and belongs to a class of drugs known as monoclonal antibodies. It works by specifically targeting and blocking the action of a protein called HER2, which is overexpressed in some types of cancer cells. By blocking HER2, Ogivri helps to slow down or stop the growth and spread